Showing results (41-50 of 238) with videos related to
Sort By:
Pageof 24
The Australian Journal of Rural Health|July 18, 2002
Increasing rural activity and curriculum content in the Adelaide University Medical SchoolCaroline Laurence, Jonathan Newbury, David WilkinsonDementia and Geriatric Cognitive Disorders|October 11, 2013
Memantine in patients with moderate to severe Alzheimer's disease: meta-analyses using realistic definitions of responseDavid Wilkinson, Yvonne Wirth, Claus GoebelCanadian Journal of Experimental Psychology = Revue Canadienne De Psychologie Experimentale|July 7, 2011
Lack of power enhances visual perceptual discriminationMario Weick, Ana Guinote, David WilkinsonDermatology Practical & Conceptual|November 14, 2025
Spontaneous Regression of Well-Differentiated Squamous Cell Skin Cancer Following Partial, Diagnostic Biopsy: Retrospective Cohort in QueenslandDavid Wilkinson, Julia Sottovia, Sonje HoogstadStem Cell Research|June 6, 2022
Generation of human induced pluripotent stem cell line from peripheral blood mononuclear cells from an activated phosphoinositide 3-kinase δ syndrome patientShuyu Fang, Anle Zeng, Qiling Xu, et al.The Journal of Clinical Endocrinology and Metabolism|February 1, 2025
Potential mechanism associated with post-heart transplantation diabetes mellitus in Chinese patientsXiao Huang, Qiling Xu, Linhua Chen, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 5, 2020
NCK1-AS1 enhances glioma cell proliferation, radioresistance and chemoresistance via miR-22-3p/IGF1R ceRNA pathwayBo Wang, Kai Wang, Tenglong Jin, et al.International Immunopharmacology|March 14, 2021
The role of probiotics in coronavirus disease-19 infection in Wuhan: A retrospective study of 311 severe patientsQiang Li, Fang Cheng, Qiling Xu, et al.BMJ Open|August 8, 2024
Comparative effect of different mindfulness-based intervention types and deliveries on depression in patients with breast cancer: a protocol for a systematic review and network meta-analysisDeqi Zhang, Wenxin Zhao, Lin Yuan, et al.The Lancet. Neurology|October 10, 2014
Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trialDavid Wilkinson, Kristian Windfeld, Eskild Colding-JørgensenPageof 24